Neurocrine Biosciences
NBIX
#1343
Rank
A$23.69 B
Marketcap
A$235.62
Share price
1.30%
Change (1 day)
22.32%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company